Assessment of potential public health impact of a quadrivalent inactivated influenza vaccine in Thailand

Influenza and other Respiratory Viruses

Volumn 10, Issue 3, 2016, Pages 211-219

  Kittikraisak, Wanitchaya ^a   Chittaganpitch, Malinee ^b   Gregory, Christopher J ^a,c   Laosiritaworn, Yongjua ^d   Thantithaveewat, Thanawadee ^d   Dawood, Fatimah S ^c   Lindblade, Kim A ^a,c  

^a Centers for Disease Control CDC Thailand Field Station   (Thailand)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Inactivated influenza vaccine; Quadrivalent; Thailand; Trivalent

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE; VIRUS ANTIBODY;

ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; HEALTH IMPACT ASSESSMENT; HOSPITALIZATION; HUMAN; INCIDENCE; OUTCOME ASSESSMENT; POPULATION PROJECTION; PRIORITY JOURNAL; THAILAND; BLOOD; COST OF ILLNESS; ECONOMICS; IMMUNOLOGY; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MORTALITY; PUBLIC HEALTH; SEASON; STATISTICAL MODEL; VIROLOGY;

ANTIBODIES, VIRAL; COST OF ILLNESS; HOSPITALIZATION; HUMANS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, STATISTICAL; PUBLIC HEALTH; SEASONS; THAILAND; VACCINES, INACTIVATED;

EID: 84957999138     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12361     Document Type: Article

References (37)

1. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012; 8:81-88.
2. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010; 28:2149-2156.
3. Centers for Disease Control Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep 2013; 62(RR-07):1-43.
4. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-1998.
5. Eichner M, Schwehm M, Hain J et al. 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis 2014; 14:365.
6. Van Bellinghen LA, Meier G, Van Vlaenderen I. The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model. PLoS ONE 2014; 9:e98437.
7. Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States. Hum Vaccin Immunother 2014; 10:1171-1180.
8. You J, Ming WK, Chan P. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong. BMC Infect Dis 2014; 14:618.
9. Crépey P, de Boer PT, Postma MJ, Pitman R. Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza Other Respir Viruses 2015; 9(Suppl 1):39-46.
10. Chit A, Roiz J, Aballea S. An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model. PLoS ONE 2015; 10:e0133606.
11. Owusu JT, Prapasiri P, Ditsungnoen D et al. Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010-2012. Vaccine 2015; 33:742-747.
12. McLean HQ, Thompson MG, Sundaram ME et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 2015; 211:1529-1540.
13. Population Projections of Thailand 2000-2030. National Economic and Social Development Board of Thailand; Available from: http://www.nesdb.go.th/temp_social/pop.zip (Accessed 20 October 2015).
14. Official Statistics Registration System. Department of Provincial Administration, Ministry of Interior; Available from: http://stat.bora.dopa.go.th/stat/(Accessed 21 October 2015).
15. Saha S, Chadha M, Al Mamun A et al. Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia. Bull World Health Organ 2014; 92:318-330.
16. Chittaganpitch M, Supawat K, Olsen SJ et al. Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004-2010. Influenza Other Respir Viruses 2012; 6:276-283.
17. Gupta V, Dawood FS, Muangchana C et al. Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011. PLoS ONE 2012; 7:e52842.
18. Olsen SJ, Laosiritaworn Y, Siasiriwattana S, Chunsuttiwat S, Dowell SF. The incidence of pneumonia in rural Thailand. Int J Infect Dis 2006; 10:439-445.
19. Baggett HC, Chittaganpitch M, Thamthitiwat S et al. Incidence and epidemiology of hospitalized influenza cases in rural Thailand during the influenza A (H1N1)pdm09 pandemic, 2009-2010. PLoS ONE 2012; 7:e48609.
20. Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect 2008; 136:852-864.
21. Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G, Kelly H. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. J Med Virol 2014; 86:1017-1025.
22. Kittikraisak W, Suntarattiwong P, Levy J et al. Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013. Influenza Other Respir Viruses 2015; 9:85-93.
23. Levy A, Sullivan SG, Tempone SS et al. Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. Vaccine 2014; 32:6312-6318.
24. Kelly HA, Sullivan SG, Grant KA, Fielding JE. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. Influenza Other Respir Viruses 2013; 7:729-737.
25. Dawood FS, Prapasiri P, Areerat P et al. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years. Influenza Other Respir Viruses 2014; 8:463-468.
26. Madhi SA, Maskew M, Koen A et al. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis 2011; 52:128-137.
27. Orellano PW, Reynoso JI, Carlino O, Uez O. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine 2010; 28:5288-5291.
28. European Centers for Disease Control and Prevention. ECDC Interim Guidance: Use of Specific Pandemic Influenza Vaccines During the H1N1 2009 Pandemic. Stockholm: European Centers for Disease Control and Prevention, 2009.
29. Dawood FS, Iuliano AD, Reed C et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012; 12:687-695.
30. Teutsch SM. Considering in planning a surveillance system; in Teutsch SM, Churchill RE (eds): Principles and Practice of Public Health Surveillance. New York: Oxford University Press, Inc., 2000; 17-29.
31. Jayasundara K, Soobiah C, Thommes E, Tricco AC, Chit A. Natural attack rate of influenza in unvaccinated children and adults: a meta-regression analysis. BMC Infect Dis 2014; 14:670.
32. World Health Organization. Vaccines against influenza. WHO position paper - November 2012. Weekly Epidemiol Record 2012; 87:461-476.
33. Cooper BS, Kotirum S, Kulpeng W et al. Mortality attributable to seasonal influenza A and B infections in Thailand, 2005-2009: a longitudinal study. Am J Epidemiol 2015; 181:898-907.
34. Aungkulanon S, Cheng P, Kusreesakul K et al. Influenza-associated mortality in Thailand, 2006-2011. Influenza Other Respir Viruses 2015; 9:298-304.
35. Kittikraisak W, Suntarattiwong P, Ditsungnoen D et al., editors. Effectiveness of the Influenza Vaccine Against Laboratory-confirmed Influenza in Young Children Using a Test-negative Design in Bangkok, Thailand, 2013-2014. Atlanta, GA, USA: International Conference on Emerging Infectious Diseases, 2015.
36. Simmerman JM, Uyeki TM. The burden of influenza in East and South-East Asia: a review of the English language literature. Influenza Other Respir Viruses 2008; 2:81-92.
37. DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012; 31:49-57.